Evolve Private Wealth LLC purchased a new position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund purchased 8,224 shares of the company’s stock, valued at approximately $3,207,000.
A number of other institutional investors and hedge funds have also bought and sold shares of HCA. BlackRock Inc. acquired a new position in shares of HCA Healthcare during the second quarter valued at about $5,069,974,000. Norges Bank acquired a new position in HCA Healthcare in the 4th quarter valued at approximately $1,262,513,000. Life Cycle Investment Partners Ltd acquired a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $374,037,000. Viking Global Investors LP lifted its position in HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares during the period. Finally, Northwestern Mutual Wealth Management Co. increased its holdings in HCA Healthcare by 4,545.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after buying an additional 649,058 shares during the period. Institutional investors own 62.73% of the company’s stock.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on HCA shares. Cantor Fitzgerald dropped their price target on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a research report on Tuesday, July 7th. Morgan Stanley dropped their target price on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a report on Monday, July 27th. Wall Street Zen lowered HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Sanford C. Bernstein reissued a “market perform” rating on shares of HCA Healthcare in a report on Wednesday, July 15th. Finally, KeyCorp dropped their target price on shares of HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating for the company in a research report on Monday, July 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $462.64.
HCA Healthcare Stock Performance
Shares of HCA opened at $429.08 on Friday. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52. The firm has a market capitalization of $92.90 billion, a price-to-earnings ratio of 14.36, a PEG ratio of 1.49 and a beta of 1.10. The business’s fifty day moving average price is $397.16 and its two-hundred day moving average price is $444.14.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. The firm had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period last year, the firm earned $6.84 earnings per share. As a group, research analysts forecast that HCA Healthcare, Inc. will post 29.47 EPS for the current year.
HCA Healthcare Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s payout ratio is presently 10.45%.
HCA Healthcare Company Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Featured Stories
- Five stocks we like better than HCA Healthcare
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
